Evidence map›Paper›PMID 38182918›Full record

ArticleNeurocritical care2024

To Accelerate the Process of Brain Death Determination in China Through the Strategy and Practice of Establishing Demonstration Hospitals.

Yingying Su, Weibi Chen, Yan Zhang, Linlin Fan, Gang Liu, Fei Tian, Huijin Huang, Lili Cui, Caiyun Gao, Yuying Su and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurocritical care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Technical Considerations in the TCD Evaluation of Cerebral Circulatory Arrest in Death by Neurological Criteria.Journal of neuroimaging : official journal of the American Society of Neuroimaging
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yingying SuDepartment of Neurology, Neurocritical Care Unit, Xuanwu Hospital, Capital Medical University, Beijing, 10053, China. suyingying@xwh.ccmu.edu.cn.
Weibi ChenDepartment of Neurology, Neurocritical Care Unit, Xuanwu Hospital, Capital Medical University, Beijing, 10053, China.
Yan ZhangDepartment of Neurology, Neurocritical Care Unit, Xuanwu Hospital, Capital Medical University, Beijing, 10053, China.
Linlin FanDepartment of Neurology, Neurocritical Care Unit, Xuanwu Hospital, Capital Medical University, Beijing, 10053, China.
Gang LiuDepartment of Neurology, Neurocritical Care Unit, Xuanwu Hospital, Capital Medical University, Beijing, 10053, China.
Fei TianDepartment of Neurology, Neurocritical Care Unit, Xuanwu Hospital, Capital Medical University, Beijing, 10053, China.
Huijin HuangDepartment of Neurology, Neurocritical Care Unit, Xuanwu Hospital, Capital Medical University, Beijing, 10053, China.
Lili CuiDepartment of Neurology, Neurocritical Care Unit, Xuanwu Hospital, Capital Medical University, Beijing, 10053, China.
Caiyun GaoBrain Death Determination Quality Control Demonstration Hospital Alliance, Beijing, China.
Yuying SuBrain Death Determination Quality Control Demonstration Hospital Alliance, Beijing, China.
Yajuan HuBrain Death Determination Quality Control Demonstration Hospital Alliance, Beijing, China.
Hongbo ChenDepartment of Neurology, Liangxiang Hospital of Beijing Fangshan District, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOur objective was to explore whether a brain death determination (BDD) strategy with demonstration hospitals can accelerate the process of BDD in China.

methodsWe proposed the construction standards for the BDD quality control demonstration hospitals (BDDHs). The quality and quantity of BDD cases were then analyzed.

resultsA total of 107 BDDHs were established from 2013 to 2022 covering 29 provinces, autonomous regions, and municipalities under jurisdiction of the central government of the Chinese mainland (except Qinghai and Tibet). A total of 1,948 professional and technical personnel from these 107 BDDHs received training in BDD, 107 quality control personnel were trained in the quality control management of BDD, and 1,293 instruments for electroencephalography, short-latency somatosensory evoked potential recordings, and transcranial Doppler imaging were provided for BDD. A total of 6,735 BDD cases were submitted to the quality control center. Among the nine quality control indicators for BDD in these cases, the implementation rate, completion rate, and coincidence rate of apnea testing increased the most, reaching 99%.

conclusionsThe strategy of constructing BDDHs to promote BDD is feasible and reliable. Ensuring quality and quantity is a fundamental element for the rapid and orderly popularization of BDD in China.

Indexed as

Brain DeathChinaElectroencephalographyEvoked Potentials, SomatosensoryHospitalsHumansQuality ControlUltrasonography, Doppler, TranscranialBrain death determinationEducationQuality controlStandardTraining

Identifiers

PMID38182918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.